Jim Blair Shares Insights on Future Direction of Genomics with Investor Business Daily
October 12, 2015Jim Blair of Domain Associates has seen genomics grow from its infancy into the rapidly developing space it is today. While genomics has made great strides, Blair foresees this is merely the beginning of a clinically rewarding development cycle.
More »
Epic Sciences’ Dena Marrinucci, PhD, Recognized for Her Outstanding Achievements in Entrepreneurial and Technical Innovation
August 18, 2015Co-founder and CSO of Epic Sciences, Dena Marrinucci, PhD, as she was recently named in the 2015 list of 100 outstanding professionals in the life-sciences industry by PharmaVOICE and today was named one of the Top Innovators Under 35 by MIT Technology Review.
More »
Medical Devices: Reducing Medical Costs and Competing for Drug Dollars
July 22, 2015Of the sectors in which Domain invests, the value of medical devices is often the least recognized. While drugs and diagnostics continue to be our focus, significant advances in the capabilities of medical devices are driving “curative” approaches, which make devices poised to actively compete in indications that are today treated with a prescription drug.
More »
Diagnostics: Realizing Personalized Medicine
July 22, 2015What will the future of diagnostics look like and how will we get there?
More »
Domain’s Top Three Takeaways from ASCO 2015
July 22, 2015If you followed the news coming out of ASCO 2015, the large oncology meeting held recently in Chicago, you will have recognized many of the themes that drive Domain's investments. Here we summarize the top three themes and feature Domain portfolio companies working to turn cancer into a managed disease.
More »